1. Home
  2. TILE vs BEAM Comparison

TILE vs BEAM Comparison

Compare TILE & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Interface Inc.

TILE

Interface Inc.

N/A

Current Price

$37.42

Market Cap

2.2B

ML Signal

N/A

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$29.38

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TILE
BEAM
Founded
1973
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
TILE
BEAM
Price
$37.42
$29.38
Analyst Decision
Buy
Buy
Analyst Count
1
12
Target Price
$36.00
$50.75
AVG Volume (30 Days)
477.4K
1.6M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
0.29%
N/A
EPS Growth
32.43
82.31
EPS
1.28
N/A
Revenue
$1,386,854,000.00
$24,000.00
Revenue This Year
$6.72
N/A
Revenue Next Year
$5.61
$33.77
P/E Ratio
$28.91
N/A
Revenue Growth
5.41
33.33
52 Week Low
$24.40
$17.74
52 Week High
$40.50
$38.26

Technical Indicators

Market Signals
Indicator
TILE
BEAM
Relative Strength Index (RSI) 49.56 53.85
Support Level $27.29 $28.40
Resistance Level $40.07 $31.98
Average True Range (ATR) 1.08 1.35
MACD -0.36 0.23
Stochastic Oscillator 11.91 67.16

Price Performance

Historical Comparison
TILE
BEAM

About TILE Interface Inc.

Interface Inc is engaged in the design, production, and sale of carpet tiles. It also provides Luxury Vinyl tiles and rubber flooring. The company mainly targets corporate and noncorporate office markets, including government, education, healthcare, hospitality, and retailers. Its geographical segments include the Americas, Europe, and Asia-Pacific. It has two operating and reportable segments- namely Americas (AMS) and Europe, Africa, Asia and Australia (collectively EAAA). Key revenue is generated from AMS segment. Its products include: ESD, Acoustic, Extreme Wear, and Quick Installation System (nTx).

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: